Philip Bredin
Dublin, L, Ireland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Dose Adjusted Neoadjuvant Paclitaxel, Carboplatin, Trastuzumab and Pertuzumab in Women With HER2 Positive Early Breast Cancer.
Journal: Clinical breast cancer
Published: July 02, 2025
Contrasting roles of KMT2C and KMT2D in breast cancer.
Journal: Scientific reports
Published: March 20, 2025
Role of immunotherapy in managing cancers prior to liver transplantation.
Journal: Current opinion in organ transplantation
Published: December 02, 2024
Neoadjuvant trastuzumab deruxtecan (T-DXd) with response-directed definitive therapy in early stage HER2-positive breast cancer: a phase II study protocol (SHAMROCK study).
Journal: BMC cancer
Published: December 20, 2023
Correction to: The gut microbiome, immune check point inhibition and immune‑related adverse events in non‑small cell lung cancer.
Journal: Cancer metastasis reviews
Published: August 18, 2022
The gut microbiome, immune check point inhibition and immune-related adverse events in non-small cell lung cancer.
Journal: Cancer metastasis reviews
Published: March 06, 2022
Systemic therapy for metastatic HER2-positive breast cancer.
Journal: Seminars in oncology
Published: July 29, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026